FCGR3B and autoimmune disease: Numerous previous studies have suggested that FCGR3B may be a risk factor for a range of autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis (28).The exact rationale for the role of FCGR3B in the treatment of CC is unclear.